Skip to content

FP7

ENABLE

European Gram Negative Antibacterial Engine

Programme
Seventh Framework Programme
Started
Ends
Duration
72 months
Total cost
EUR 100,832,798
EU contribution
EUR 58,900,000
Participants
47 from 13 countries
Topic
FP7_IMI-JU-08-2012-02-01
Grant agreement
115583

Coordinated by Glaxosmithkline Research & Development Limited (GBUnited Kingdom).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium, coordinator first
OrganisationCountryRoleEU contributionRecognised by
Glaxosmithkline Research & Development LimitedGBUnited KingdomCoordinatorNot statedPIC (1.00)
Asclepia Outsourcing SolutionsBEBelgiumParticipantEUR 610,400PIC (1.00)
European Biotechnology Network aisblBEBelgiumParticipantEUR 285,240PIC (1.00)
Universite de LiegeBEBelgiumParticipantEUR 27,580known name (0.95)
Basilea Pharmaceutica International AGCHSwitzerlandParticipantNot statedPIC (1.00)
Juvabis AGCHSwitzerlandParticipantEUR 726,405PIC (1.00)
Universitat ZurichCHSwitzerlandParticipantEUR 1,985,780known name (0.95)
Bioresources Technology & Engineering GmbHDEGermanyParticipantEUR 86,580PIC (1.00)
Forschungszentrum Borstel Leibniz LungenzentrumDEGermanyParticipantEUR 567,678known name (0.95)
Helmholtz-Zentrum Fur Infektionsforschung GmbHDEGermanyParticipantEUR 448,562known name (0.97)
MPS Hamburg GmbHDEGermanyParticipantNot statedPIC (1.00)
Kobenhavns UniversitetDKDenmarkParticipantEUR 1,938,693known name (0.95)
Region HovedstadenDKDenmarkParticipantEUR 1,011,953known name (0.95)
Statens Serum InstitutDKDenmarkParticipantEUR 962,561known name (0.95)
Biomol-Informatics SLESSpainParticipantNot statedPIC (1.00)
Fundacion Centro de Excelencia en Investigacion de Medicamentos Innovadores en AndaluciaESSpainParticipantEUR 215,775VAT number (0.97)
Servicio Madrileno de SaludESSpainParticipantEUR 586,800known name (0.97)
Universitat de BarcelonaESSpainParticipantEUR 44,340known name (0.97)
Helsingin YliopistoFIFinlandParticipantEUR 1,030,230known name (0.95)
Northern Antibiotics OyFIFinlandParticipantEUR 115,994PIC (1.00)
Centre National de la Recherche Scientifique CnrsFRFranceParticipantEUR 364,224known name (0.95)
MutabilisFRFranceParticipantEUR 3,408,564PIC (1.00)
NosopharmFRFranceParticipantEUR 1,150,090PIC (1.00)
Sanofi-Aventis Recherche & DeveloppementFRFranceParticipantNot statedPIC (1.00)
Aston UniversityGBUnited KingdomParticipantEUR 240,646known name (0.95)
Cardiff UniversityGBUnited KingdomParticipantEUR 1,275,588known name (0.95)
Helperby Therapeutics LtdGBUnited KingdomParticipantEUR 104,120PIC (1.00)
Inspiralis LtdGBUnited KingdomParticipantEUR 207,168PIC (1.00)
John Innes CentreGBUnited KingdomParticipantEUR 351,120known name (0.95)
Molecular Discovery LtdGBUnited KingdomParticipantEUR 455,910PIC (1.00)
Redx Pharma LtdGBUnited KingdomParticipantEUR 583,724PIC (1.00)
Spero Europe LimitedGBUnited KingdomParticipantEUR 41,460PIC (1.00)
St George's Hospital Medical SchoolGBUnited KingdomParticipantEUR 92,200PIC (1.00)
The Chancellor, Masters and Scholars of the University of OxfordGBUnited KingdomParticipantEUR 2,955,788PIC (1.00)
The Research Network Ltd.GBUnited KingdomParticipantEUR 277,085PIC (1.00)
The University Court of the University of St AndrewsGBUnited KingdomParticipantEUR 15,764PIC (1.00)
Agencia Estatal Consejo Superior de Investigaciones CientificasITItalyParticipantEUR 54,953PIC (1.00)
Latvijas Organiskas Sintezes InstitutsLVLatviaParticipantEUR 5,904,839known name (0.95)
Stichting VuNLNetherlandsParticipantEUR 1,969,634known name (0.95)
Narodowy Instytut LekowPLPolandParticipantEUR 288,000known name (0.97)
Astrazeneca ABSESwedenParticipantNot statedPIC (1.00)
Beactica Therapeutics ABSESwedenParticipantEUR 169,699PIC (1.00)
Karolinska InstitutetSESwedenParticipantEUR 877,980known name (0.95)
KeytoLead ABSESwedenParticipantEUR 3,721PIC (1.00)
Recipharm OT ChemistrySESwedenParticipantEUR 2,314,926PIC (1.00)
Rise Research Institutes of Sweden ABSESwedenParticipantEUR 3,395,700known name (0.95)
Uppsala UniversitetSESwedenParticipantEUR 21,752,526known name (0.95)

Changes of the consortium

First seen on with 47 participants from 13 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.